Your healthcare provider considers your treatment goals, current health status, medication tolerance, and response to therapy when establishing and adjusting your dosing regimen
Plaintiffs argue that although the drug labels contained warnings, the pharmaceutical companies downplayed the potential severity of the gastrointestinal issues
The control group required greater use of inotropic and vasoactive infusions during the 48 h period after CABG to achieve the same hemodynamic results observed in the group receiving GLP-1
In the days following your first semaglutide GLP-1 injection, you may not see immediate changes in appetite or weight, as the medication works gradually to regulate hunger and improve metabolic function
Causal factors for knee, hip, and hand osteoarthritis: a Mendelian randomization study in the UK biobank
Compared to usual care, GLP-1RA use was associated with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions